Fifty-two-week, randomized, multicenter trial to compare the safety and efficacy of the novel glucagon-like peptide-1 analog liraglutide vs glibenclamide in patients with type 2 diabetes
Kohei Kaku, Mads Frederik Rasmussen, Tomoyuki Nishida, Yutaka SeinoVolume:
2
Year:
2011
Language:
english
DOI:
10.1111/j.2040-1124.2011.00128.x
File:
PDF, 189 KB
english, 2011